Mario Negri Institute for Pharmacological Research clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 159 studies whose lead sponsor is Mario Negri Institute for Pharmacological Research. 36 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.
Keep track of what changes. Save the Mario Negri Institute for Pharmacological Research studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesFocus areas
Conditions Mario Negri Institute for Pharmacological Research leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 159. Browse all 159 →
- Premedication With Dexamethasone for Preventing Interstitial Lung Disease in Patients With Breast Cancer Treated With Trastuzumab DeruxtecanNot yet recruitingNCT07828054Phase 3
- Development of a Multipurpose Dashboard to Monitor the Situation of Emergency DepartmentsRecruitingNCT06372379
- Propensity to Hospitalize Patients From the ED in European Centers.RecruitingNCT06354764
- Severe Acquired Brain Injuries: Prognostic Factors and Quality of CareRecruitingNCT04905264
- RESOLving INflammation Through Diet for Health (RESOLVIN)RecruitingNCT07331103Not applicable
- Emergency and Urgent Care Indicators in PiedmontNot yet recruitingNCT07606209
- Mild TBI in the Emergency DepartmentRecruitingNCT07021118
- Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALSRecruitingNCT06126315Phase 2/3
- Implementation of New Models of Ovarian Carcinoma Resistant to TherapyNot yet recruitingNCT07757711
- Development of a Natural Language Processing Tool to Enable Clinical Research in Emergency MedicineRecruitingNCT06240572
- Trauma Molecular ProcessesRecruitingNCT07683169
- Thyroid Hormones in CKDNot yet recruitingNCT07663773
- Health-care Quality in Semi-intensive Care UnitsRecruitingNCT04676347
- Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of HospitalizationsRecruitingNCT06846879
- Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and SenescenceNot yet recruitingNCT07596615Not applicable
- Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare DiseasesRecruitingNCT05996731Not applicable
- An Outcome Analysis of Primary Membranous NephropathyRecruitingNCT06242327
- Autoreactive B Cells in Membranous NephropathyRecruitingNCT04095156
- Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and AbemaciclibNot yet recruitingNCT07428018Phase 2
- Omics of Rituximab-resistanceNot yet recruitingNCT07416942
- Obinutuzumab in Adult Rituximab-Dependent Nephrotic SyndromeNot yet recruitingNCT07233330Phase 2
- AVF-MONITOR POC Proof-of-concept StudyNot yet recruitingNCT07318025Not applicable
- Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC RegimenRecruitingNCT06680050Phase 2
- Mechanisms Underlying SGLT2i Kidney Effect in DKD ProgressionNot yet recruitingNCT07270198Not applicable
- Functional Implications of Rare Gene Mutations in aHUS Open the Door to Personalized TherapyRecruitingNCT05805202Not applicable
- CardioPulmonary Resuscitation With Argon (CPAr) TrialRecruitingNCT05482945Phase 2
- New Advanced Vascular Imaging Ultrasound ProtocolsRecruitingNCT06841887
- Autoantibodies Against-nephrin in Idiopathic Nephrotic SyndromeRecruitingNCT06334692
- Patiromer and Diet/hrQoL in Chronic DialysisRecruitingNCT06858280Phase 3
- Blood Flow Conditions and Sounds in AVFsRecruitingNCT06411353Not applicable
- Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI ScannersRecruitingNCT06884410Not applicable
- Acoustic Analysis of VA SoundsRecruitingNCT05612022
- Kidney Perfusion With or Without AbsorptionRecruitingNCT06374121Not applicable
- Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.RecruitingNCT03914820Not applicable
- Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Gastric Carcinoma.GOETH StudyRecruitingNCT03917173Not applicable
- Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older PatientsNot yet recruitingNCT05976477Not applicable
- Obinutuzumab in Primary MNCompletedNCT05050214Phase 2
- MOR202 for Refractory MNCompletedNCT04893096Phase 2
- First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive PatientsActive, not recruitingNCT06121401Phase 4
- Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (Fondazione IRCCS Ca' Granda Ospedale Maggione Policlinico)Active, not recruitingNCT06345352
- A New Crowding Indicator in the Emergency DepartmentActive, not recruitingNCT07111624
- Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Admissions of Patients Accessing the Emergency Department (ASST Papa Giovanni XXIII)Active, not recruitingNCT06345378
- A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo ProvinceCompletedNCT06594367
- New Analytic Tools for aHUS and C3G DiagnosisActive, not recruitingNCT05985122Not applicable
- Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous NephropathyCompletedNCT06994468Not applicable
- Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.CompletedNCT04794127Phase 2
- Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast CancerTerminatedNCT04113863Phase 2
- Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLCTerminatedNCT04765709Phase 2
- MuLtidimensional School-based and Family interVentions to Promote hEalthy and Sustainable LifestYle for the ChildhoodCompletedNCT05966051
- Outcome of ADPKD With Octreotide LARActive, not recruitingNCT06193616